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ACCELERATION OF BONE FRACTURE HEALING THROUGH THE USE OF NATURAL 
BOVINE HYDROXYAPATITE IMPLANT ON BONE DEFECT ANIMAL MODEL 
 
Junaidi Khotib1, Cantika SC Lasandara2, Samirah1, Aniek S Budiatin1  
1Department of Clinical Pharmacy, 2Postgraduate Student of Master of Pharmaceutical Science, Faculty of Pharmacy, 
Universitas Airlangga, Surabaya, Indonesia 
 
 
ABSTRACT 
 
Bone is an important organ for supports the body that stores reserve of calcium, phosphorus, and other minerals. In fracture 
conditions where bleeding, soft tissue edema, nerve damage, and blood vessels around the bone damage happen, they can cause the 
mobilization of these minerals in the surrounding tissue. One of the efforts made in the treatment of these fractures is reconnection, 
in which it works by filling of bone defect with a matrix and administration of anti-infection. Biomaterial filling in defective bone is 
thought to accelerate the healing process of bone fracture and prevent osteomyelitis. For this reason, this study evaluates the 
acceleration of bone fracture healing using natural hydroxyapatite (NHA) bone filler in rabbits with bone defect model. Fracture 
modeling was performed by surgical technique and drilling of bones with a 4.2 mm diameter to form a defect in the rabbit femur. 
Bone implant contained bovine hydroxyapatite-gelatin-glutaraldehyde (BHA implant) or bovine hydroxyapatite-gelatin-
glutaraldehyde-gentamicin (BHA-GEN implant) that was inserted in bone defects. 27 rabbits were divided into 3 groups: the control 
group who had bone defect, the bone defect group was given BHA implant and the bone defect group was given BHA-GEN implant. 
Observation of osteoclast, osteoblast, osteocyte, BALP level, and bone morphological integrity was carried out on the 14th, 28th, and 
42nd days after surgery. Histological observation of rabbit femur showed a significant difference on the number of osteoclast, 
osteoblast and osteocyte in all three groups. The BALP level also showed a significant difference in the group given the natural BHA 
bone implant compared to the control group on day 14 (p = 0.0361). Based on the result of the X-ray, there was also a better 
integration of rabbit femur bone in groups with the use of BHA or BHA-GEN bone implant. Thus, it can be concluded that the use of 
a natural BHA implant can accelerate the process of bone repair in the fracture of rabbit femur. In addition, BHA implants were 
compatible as a matrix for supporting the bone cell growth. 
 
Keywords: Bone remodeling; fracture; natural bovine hydroxyapatite; bone alkaline phosphatase  
 
 
ABSTRAK 
 
Tulang merupakan organ penting penyangga tubuh yang menyimpan cadangan kalsium, fosfor dan mineral lainnya. Pada keadaan 
fraktur dimana terjadi perdarahan, edema jaringan lunak, kerusakan saraf dan kerusakan pembuluh darah di sekitar tulang dapat 
menyebabkan terjadinya mobilisasi mineral tersebut pada jaringan sekitarnya. Salah satu upaya yang dilakukan dalam penanganan 
patah tulang adalah penyambungan kembali, pengisian defek tulang dan pemberian anti infeksi. Pengisian biomaterial pada tulang 
yang defek diduga dapat mempercepat proses penyembuhan tulang yang patah dan mencegah terjadinya infeksi. Untuk itu pada 
penelitian ini dilakukan pengujian dengan menggunakan natural bone filler bovine hydroxyapatite (NHA) dalam penanganan defek 
tulang pada hewan coba kelinci. Pembuatan model fraktur dilakukan dengan teknik pembedahan dan pengeboran tulang dengan 
mata bor 4.2 mm sehingga terbentuk defek (lubang) pada tulang femur kelinci. Implan tulang yang mengandung bovine 
hydroxyapatite (implan BHA) atau bovine hydroxyapatite dengan antibiotika gentamisin (implan BHA-GEN) disisipkan pada defek 
tulang yang telah dibuat. 27 ekor kelinci dibagi dalam 3 kelompok yaitu kelompok kontrol yang mengalami defek tulang, kelompok 
defek tulang dengan pemberian BHA dan kelompok defek tulang dengan pemberian BHA-GEN. Pengamatan osteoklas, osteoblas, 
osteosit, kadar BALP dan keutuhan morfologi tulang dilakukan pada hari ke 14, 28 dan 42 setelah operasi. Pengamatan histologi 
pada tulang femur kelinci menunjukkan adanya perbedaan signifikan jumlah osteoklas, osteoblas dan osteosit pada ketiga kelompok. 
Kadar BALP juga menunjukkan perbedaan bermakna kelompok yang diberikan implan BHA atau BHA-GEN dibanding kelompok 
yang tidak diberikan implan tulang pada hari ke-14 (p = 0,0361). Berdasarkan hasil X-Ray juga terjadi penyatuan yang lebih baik 
tulang femur kelinci pada kelompok dengan penggunaan implan tulang. Dengan demikian dapat disimpulkan bahwa penggunaan 
natural implan BHA dapat mempercepat proses perbaikan tulang pada femur kelinci yang mengalami fraktur dan BHA mempunyai 
compatibilitas yang baik sebagai matriks pendukung pertumbuhan sel tulang. 
 
Kata kunci: Bone remodeling; fracture; natural bovine hydroxyapatite; bone alkaline phosphatase 
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INTRODUCTION  
 
Bone is one of the most important parts of the human 
body cantilever, serves as a support for muscle, protects 
vital organs such as the brain and thoracic cavity, and is 
where bone marrow forms blood cells. Bone is also a 
storage place for calcium, phosphorus, and other ions 
that can be released or stored to maintain a constant 
level of these ions in body fluid (Seibel 2000, Pagani 
2005). Fracture is a condition of bone continuity that 
results from direct or indirect injury. In a fracture, the 
surrounding tissue will also be affected where soft tissue 
edema will occur, bleeding, nerve damage, and blood 
vessels around the bone damage (Brunner 1997, 
Einhorn 2010).  
 
In Indonesia, the number of fracture event is quite high. 
Based on the data from the Ministry of Health of the 
Republic of Indonesia, eight million people experience 
fracture events with different types and causes. From 
the Ministry of Health's survey report, it is found that 
25% of patients with fractures have died, 45% have 
physical disabilities, 15% have lost some bones and 
suffered injuries, and 10% have recovered well. One 
effort that has been developed to reduce the occurrence 
of bone defect and overcome the problem of bone gap is 
the use of bone graft. Bone graft is a surgical procedure 
that places new bone or substitute material (composite 
matrix) into the space around a fracture or where it has a 
gap (defect) (Helmi 2014). In the use of bone graft, it 
will stimulate the process of osteogenesis through 
osteoblast activation in the area around the defect. In 
addition to osteoconductive, there is an osteoinductive 
process, which is related to the formation of new bone 
through the stimulation of osteoprogenitor cell that 
comes from the defect to differentiate into osteoblast 
and form new bone (Ferdiansyah et al 2010).  
 
Metabolically active bone undergoes continuous 
remodeling through two processes, namely the 
formation and resorption of bone. These processes 
depend on the activity of osteoclast, osteoblast, and 
osteocyte. These active and dynamic processes depend 
on the balance between the process of bone resorption 
by osteoclast and bone deposition by osteoblast. These 
two functions must be balanced both quantitatively and 
functionally (Chen et al 2012, Sihombing et al 2012).  
 
Implant inserted in bone defect can also contain an 
antibiotic that works locally to prevent infection. The 
release of antibiotic is done with a modified release 
design so that it can cover during the bone healing 
process. One way to do this is to add a composite with 
cross-link agent (crosslinking material). Some 
chemicals that can be used as cross-link ingredients are 
proteins, including glutaraldehyde, formaldehyde, 
polyepoxy, acylazide, carbodimiides, and hexamethy-
lene diisocyanate (Marsell et al 2011, Budiatin et al 
2013, Schlickewei et al 2013). Preliminary research 
shows that the cross-link ingredients such as 
glutaraldehyde (GA) has advantages such as being 
soluble in water, requiring low concentrations, forming 
covalent bonds, and having low boiling point (40ºC). 
The residue can be removed by washing or heating 
while drying the granule for 24 hours at 40ºC, and 
accelerating calcification in tissue defect (Budiatin et al 
2014). Gentamicin is a bactericidal choice of antibiotic 
used as prophylaxis and the next stage of therapy. 
Gentamicin is released by diffusion from the matrix and 
penetrated into the bone (Budiatin et al 2013). 
 
 Fracture treatment requires a long time and the 
concentration of released antibiotic must be greater than 
the minimum inhibitory concentration (MIC) so that it 
can eradicate the bacteria that enter the bone during 
surgery. A matrix is needed as a carrier that is able to 
control the release of antibiotic that enters the local 
blood circulation to the site of infection at the 
remodeling stage. If infection can be avoided then the 
remodeling process runs quickly (Askarzadeh et al 
2005, Azami et al 2012, Budiatin et al 2013).  
 
Hydroxyapatite (HA) is the main inorganic component 
of bone, used in a variety of bone filling and 
replacement application because it has good 
biocompatible, biointegrating, and osteoconductive 
property (Capra et al 2011, Cattalini et al 2012, Chang 
et al 2015). However, HA has a disadvantage, in 
addition to its high price, HA as a synthetic material can 
also cause residual base ingredient to form 
hydroxyapatite. To overcome these weaknesses, natural 
hydroxyapatite which is an inorganic component of cow 
bone can be used as an alternative composite component 
which has several advantages including being more 
porous and having the ability to adsorb antibiotics as 
active ingredients such as antibiotics, hormones, or 
growth factors (Budiatin et al 2014). In addition, the 
natural composition of hydroxyapatite (NHA) derived 
from bovine bone consists of 93% of hydroxyapatite 
(Ca10(PO4)6(OH)2) and 7% of β-tricalcium phosphate 
(Ca3(PO4)2,ß-TCP) and has properties similar to human 
bone minerals. NHA is also thought to have excellent 
biocompatibility, high bioactivity potential in bone 
tissue reconstruction, low biodegradation, and 
osteoconductive property (Kusrini et al 2012; Chang et 
al 2015). The biocompatible nature and great porosity of 
NHA cause it becomes insoluble and unabsorbed so that 
it is ideal to act as a substitution material in the 
formation of new bone (Cottrell et al 2010, Budiatin et 
al 2014).  
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Gelatin is a protein produced from the collagen fiber of 
connective tissue, skin, bone, and cartilage hydrolyzed 
by acidic or basic process (Budiatin et al 2013). Gelatin 
is also produced by osteoblast to form osteoid (soft 
callus). By using the NHA matrix, it will be able to bind 
the active ingredients more strongly, besides that it is 
also biodegradable, biocompatible, bioresorptable, non-
toxic, and can be united with the surrounding bone 
(Budiatin et al 2013; Budiatin et al 2014, Chao et al 
2015). Gelatin as the main component in soft callus 
creation will quickly form a trabeculae that connects the 
two sides of the defect, so the bones are interconnected. 
BHA implant absorbs body fluid, expand, and form 
canals or occur vascularization, making it easier for 
cells to penetrate. BHA implant can function as an 
implant to proliferate and differentiate cell into 
osteocyte (hard callus) that closes the defect (Budiatin et 
al 2014). Bone growth begins with the formation of 
osteoid by osteoblast of which 90% of the main 
constituent is type 1 collagen which is the result of 
gelatin degradation in the implant. Degradation results 
from BHA implant that supports the process of bone 
remodeling by forming osteocytes. This phenomenon is 
a good process for accelerating the closure of bone 
defect (Raggatt & Partridge 2010, Ramirez-Fernandez 
et al 2011). Bone growth can be evaluated semi-
quantitatively from the result of X-ray observation using 
Lane & Sandhu scoring (Budiatin et al 2014).  
 
Bone alkaline phosphatase (BALP) enzyme is a 
metalloenzyme that is produced when osteoblast cell is 
working (Ellis & Kathleen 2007, Greenblatt et al 2017). 
BALP prepares an alkaline atmosphere in the formed 
osteoid tissue so that calcium can be easily deposited in 
the tissue. In addition, this enzyme causes an increase in 
phosphate concentration so that calcium-phosphate 
bonds are formed in the form of HA. Thus, BALP can 
be used as an initial marker of osteoblast differentiation 
and increase when progressive differentiation of 
osteoblast occurs (Boanini et al 2008, Goes et al 2012). 
   
 
MATERIALS AND METHODS 
 
This was an experimental study with post-test only 
control group design by using rabbits as the 
experimental animals with a fracture model on the 
femur. A total of 27 strained New Zealand rabbits aged 
between 4-8 months in health and no visible disruption 
in the rabbit femur were randomly divided into three 
groups namely the control group, the BHA implant 
group, and the BHA-GEN implant group. The rabbits 
were treated in a cage with a room temperature of 25 ± 
1ºC with 12 hours of dark lighting and 12 hours of light 
in the Animal Laboratory, Faculty of Pharmacy, 
Universitas Airlangga, Surabaya. Food and water were 
maintained in sufficient quantities during the study. 
Before being treated, the rabbits were adapted to the 
environment for 2 weeks. Peripheral blood samples 
were taken through the ear vein for BALP base line 
examination before surgery and implantation. All 
maintenances and actions on experimental animals had 
received approval from the animal ethics committee of 
the Faculty of Veterinary, Universitas Airlangga, 
Surabaya. 
 
Research materials used in this study were BHA and 
BHA-GEN implants, sterile purified water, NaCl 0.9% 
(pharmaceutical grade), ELISA Kit Catalog No. CSB-E 
12088f, xylazine (pharmaceutical grade), gentamicin 
(pharmaceutical grade), ampicillin (pharmaceutical 
grade), ketamine (pharmaceutical grade), betadine, 
savlon, alcohol 70% (pharmaceutical grade). Whereas, 
the tools were Syringe injection 1 cc, bistoury surgical 
knife no. 15, bone drill, silk suture no 3.0, circle 
needles/surgical needles, light microscope, X-ray, and 
ELISA reader.  
 
Natural bovine hydroxyapatite (NHA) (8 g) was added 
20% gelatin (5 ml) and/or 10% gentamicin and stirred 
until homogeneous to form a mass that could be made 
into granules. The granules were dried and then soaked 
in 2 ml of 5% glutaraldehyde (GA) solution in saline 
phosphate buffer (SPB) to 100.0 ml. The granules were 
washed to GA free with distilled water and dried at 
40°C for 24 hours, then weighed 100.0 mg and 
compressed in a 4 mm diameter mold with a pressure of 
0.5 tons (Budiatin et al 2014). Bone sample was 
immersed and fixed in 10% formalin for 3 days at room 
temperature. Furthermore, the decalcification process by 
immersion in ethylene diamine tetra acetic acid (EDTA) 
10% was done at pH 7.4 for 30 days at room 
temperature. 10% EDTA solution was replaced every 3 
days. 
 
The femur was irradiated with X-ray on days 14, 28 and 
42 to determine the gap development (defect) of bone 
and integrity after implantation. After BHA and BHA-
GEN implants were irradiated for 14, 28 and 42 days, 
blood sample was taken through the rabbit ear vein. The 
serum was separated and used in the determination of 
BALP by the Elisa method. 100 microliter of serum was 
entered into the well and incubated at 370C in standard 
fluid for 2 hours. The filtrate was removed then added 
with 100 microliter of biotin antibody solution and 
incubated for 1 hour. The filtrate was removed and 
washed with washing buffer liquid for 3 times (5). Next, 
100 microliters of horse radish peroxidase (HRP)-avidin 
conjugated solution were added and incubated for 1 
hour at the temperature of 370C. The filtrate was 
removed and washed with washing buffer for 3 times 
and added 90 microliters of tetra methyl blue (TMB) 
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substrate liquid and incubated for 30 minutes in a dark 
room with the temperature of 370C. The reaction was 
ended with the addition of a 50 microliter of stop 
solution liquid then read with a microplate reader at the 
wavelength of 450 nm. 
 
Histopathological approach with hematoxylin eosin 
(HE) staining was used for the examination of 
osteocyte, osteoblast, and osteoclast (Fischer et al 
2008). Tissue pieces were stained with Hematoxylin 
Mayer’s solution for 3 minutes. The slide was soaked in 
water for 5 minutes. Subsequently, it was dipped in 
alcohol 8-12 times and washed with running water for 
several minutes. Performing counterstaining in eosin 
working solution for 15 seconds to 2 minutes depending 
on the desired color level. It was later hydrated in serial 
alcohol concentrations with gradations increasing from 
70% to 100%, each for 2 minutes. The slide was cleared 
with xylene for 3x15 minutes. The calculation of the 
number of osteoblast, osteoclast, and osteocyte was 
using a digital 400 times magnification microscope as 
many as 10 fields.  
 
The research data obtained were tested for normality 
using the Kolmogorov-Smirnov test followed by the 
Lavene test for equality of variances. Data analysis was 
performed with Anova test to compare between groups 
and continued with post-Hoc Turkey’s HSD.  
 
 
RESULTS 
 
Development of bone fracture animal model 
 
The study was conducted using 27 New Zealand rabbits 
aged 3-4 months old with the weight of 2.3 kg - 2.5 kg. 
The adaptation of the rabbits was carried out for 2 
weeks and given standard feed and water in the amount 
of ad libitum. Rabbits were divided into 3 groups: 
fracture group (control) with 9 rabbits, fracture group 
that was given BHA (bovine hydroxyapatite-gelatin-
glutaraldehyde) implant with 9 rabbits, and fracture 
group that was given BHA-GEN implant (bovine 
hydroxyapatite-gelatin-glutaraldehyde-gentamicin) with 
9 rabbits. Rabbits were anesthetized with xylazine 2 
mg/kg of body weight and ketamine 20 mg/kg of body 
weight. The furs of the rabbits were shaved and given 
povidone iodine antiseptic. Furthermore, the rabbit 
femur bone was incised and drilled. The bone fracture 
model was made by drilling until a 4.2 mm of bone 
defect occurred in the rabbit femur. Infection was 
prevented by intra-muscular ampicillin 25 mg/kg of 
body weight. Placebo or BHA implant or BHA-GEN 
implant (as in Fig 1) was mounted on the hole. The 
wound was cleaned with a cotton swab soaked in NaCl 
solution and sewn again. Furthermore, wound care was 
done every day. Observation of bone repair was 
monitored on days 14, 28, and 42. The termination was 
carried out on day 42, rabbit femur was taken, and some 
biomarker parameters were set as markers of bone 
remodeling acceleration.  
 
The morphological observation of rabbit distal 
femur  
 
To determine the growth of rabbit bone morphology 
after implant placement in the fracture condition, rabbit 
surgery was performed from each control treatment 
group, BHA implant group, and BHA-GEN implant 
group. The bone was taken then histochemical prepared 
with HE staining, then the cell in the bone fragment was 
observed in 10 visual field with a light microscope at 
100x magnification. Using HE staining, the control 
bone preparation for 42 days showed that the defect had 
formed a compact bone structure. Osteocytes had spread 
evenly in the lament that surrounded the heavers' duct 
(as in Figure 2). The new bone structure that was 
formed was thought to have density and structure that 
resembled the surrounding bone. Bone preparations 
from the BHA or BHA-GEN implant group for 14 to 42 
postoperatively showed connective tissue that was still 
enveloping implant such as capsule, the connective 
tissue still did not appear to proliferate into the implant. 
The implant also looked intact. Figures 3 and 4 showed 
the change of new bone growth that was seen only in 
the edge of bone defect bordering the connective tissue 
that surrounded the BHA and BHA-GEN implants. This 
new bone tissue that growed up did not enter the 
implant. As a result there was no direct bond between 
the implant and bone tissue. There was a clear line 
between new bone tissue, connective tissue, and 
implant. The new bone tissue formed was still visible as 
woven bone formed in the early months of the bone 
healing process (bony callus). Woven bone could be 
seen from the form of its collagen fibers that were 
arranged randomly, as well as irregular vascular cavity 
shapes (Kalfas 2001, Einhorn 2010). The stage of bone 
growth was evaluated through the number of osteoclast, 
osteoblast, and osteocyte bone cells on days 14, 28, and 
42 using a light microscope. The difference in growth 
visually could be seen in Figs. 2-4 and Table 1. 
 
Radiological examination from the development of 
bone defect healing 
 
The result of radiological observations with X-ray 
device could reveal the development of bone healing 
around the BHA and BHA-GEN implants starting on 
days 14, 28, and 42 as shown in Figures 5, 6, and 7. 
Treating without implantation and installation of a BHA 
or BHA-GEN implant showed the size of the defect was 
getting smaller through X-ray imaging result from days 
14, 28, to 42. 
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Fig. 1. Bovine hydroxyapatite-gelatin-glutaraldehyde/BHA (A) and bovine hydroxyapatite-gelatin-glutaraldehyde-
gentamicin/BHA-GEN (B) implants with a diameter of 4.0 mm that were used as bone fillers in this study. 
 
 
Table 1.   The number of osteoclasts, osteoblasts, and osteocytes in the defective bone (fracture model) on days 14, 28 
and 42 after induction of bone defect and implant placement 
 
 
 
 
 
 
 
 
 
 
 
 
The result of BALP level analysis 
 
Bone alkaline phosphatase in the mineralization process 
served to prepare the alkaline atmosphere in the osteoid 
tissue that was formed so that calcium could be easily 
deposited in the tissue. In addition, this enzyme caused 
an increase in phosphate concentration so that calcium-
phosphate bonds were formed in the form of 
hydroxyapatite. Measurement of mineralization level 
was proportional to the level of BALP. On the 14th day, 
there was a significant difference in the level of BALP 
between the BHA and BHA-GEN treatments using 
Turkey's multiple comparison test (as in Table 2). 
BALP biomarker found in bone showed early 
differentiation of osteoblast from mesenchymal cell and 
played an important role in osteoid formation and 
mineralization by means of degradation from inhibitor 
mineralization. Alkaline phosphatase degraded matrix 
that was rich of proteoglycan and hydrolyzed high ester 
energy to provide phosphate ion resulting in the 
deposition of minerals with calcium in a collagen-rich 
matrix network. Determination of calcium and 
phosphate minerals with ALP could cause bone 
formation so that when bone formation could be 
improved, then the fracture healing could also be faster.  
 
 
DISCUSSION 
 
This research was conducted to examine the process of 
accelerating bone remodeling in the condition of a 
fracture or defect using the NHA composite biomaterial 
implantation in the form of BHA and BHA-GEN 
implants. NHA biomaterial composition obtained from 
bovine bone has similarity with bone composition in 
humans. BHA and BHA-GEN implants are thought to 
accelerate bone growth acceleration. This is because 
some components such as HA and gelatin can stimulate 
the activity of osteoblast to form osteoid where this 
process will accelerate the reaction of hard callus bone 
formation (osteocyte). For this reason, the development 
of fracture model in the femur illustrates a state of 
continuity of bone continuity so that it is very 
appropriate for the use of implant in an effort to connect 
broken bones. Making a fracture model is done by 
drilling a bone method with a 4.2 mm drill bit to form a 
Group 
Average cell count (X ± SD) 
Osteoclasts Osteoblast Osteocytes 
Control 14 0.66 ± 0.57 102.00 ± 22.27 185.00 ± 80.55 
Control 28 1.33 ± 0.57 112.33 ± 10.96 215.33 ± 95.65 
Control 42 2.50 ± 0.70 188.00 ± 91.92 131.50 ± 47,37 
BHA 14 2.66 ± 1.54 202.33 ± 27.42 191.66 ± 44.11 
BHA 28 2.66 ± 0.57 264.60 ± 20.50 299.00 ± 40.13 
BHA 42 3.00 ± 0.70 241.50 ± 42.42 241.00 ± 14.14 
BHA-GEN 14 3.33 ± 1.52 274.33 ± 39.52 277.60 ± 23.77 
BHA-GEN 28 3.50 ± 0.70 210.50 ± 12.37 204.50 ± 37.46 
BHA-GEN 42 3.00 ± 1.73 295.00 ± 22.11 308.50 ± 36.50 
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defect (hole). Thus, the implantation of BHA and BHA-
GEN with a diameter of 4.0 mm in rabbit femur can be 
done well. The process of healing fracture and repairing 
bone tissue involves an initial anabolic phase 
characterized by an increase in tissue volume associated 
with de novo recruitment and differentiation of stem cell 
that form bone and Callus cartilage tissue blood vessel 
around the fracture area. This process will occur from 
the periphery to the center of the fracture to the end of 
the cartilage network (Einhorn 2010, Einhorn & 
Gesternfeld 2015, Hikmawati et al 2019). 
 
The use of autograph, for bone defects is very limited 
due to donor limitation, causing pain and damage to the 
part taken. Defect causes damage to blood vessel, 
connective tissue, and surrounding muscle tissue which 
will affect the duration of healing of the defect. Given 
this limitation, it is necessary to have suitable 
biomaterials as bone replacements or implants 
(Schlickewei et al 2015, Ning et al 2017). Bone is 
externally covered by a tissue called the periosteum. 
Periosteum contains blood vessel, thick layer of 
collagen fiber that is arranged in a dense irregularity, 
and cell that is able to differentiate into osteoblast 
(osteogenic cell). All parts of the bone are covered by 
the periosteum, except those which are articulated with 
other bones. Bone has an internal space in the middle of 
the marrow cavity, in which there is stem cell from 
blood cell. The marrow cavity is coated by a layer of 
thin vascularized connective tissue called the 
endosteum. Endosteum also has osteogenic cell as does 
the periosteum (Kalfas 2001, Kim et al 2004, Maulida et 
al 2015). 
 
Bone is composed of three main cell types, namely 
osteoblast, osteocyte, and osteoclast. Osteoblast is a cell 
that plays a role in the activity of bone organic 
component synthesis, which is referred to as prebone or 
osteoid. Osteoblast is located in a line along the surface 
of bone tissue. When active, osteoblast tends to be cube 
shaped and basophilic in nature. Meanwhile, when less 
active, the shape will become more flat and less 
basophilic. HE staining is often used and able to daub 
the nucleus and cytoplasm, HE staining uses 2 kinds of 
staining agents namely hematoxylin which functions to 
daub the cell nucleus and gives a blue color and eosin 
which is used to daub the cytoplasm of cells (Fischer et 
al 2008). Histological testing of rabbit femur bone from 
each control treatment group, the BHA implant group, 
and the BHA-GEN implant group is to determine the 
bone growth process that occurred after the fracture. 
The method used in this examination is a quantitative 
method, which is determined by adding all the target 
cells found in 10 (ten) different visual fields with a 
magnification of 100 times.  
 
In the process of bone fracture healing, it appears that 
the control group without implant provides a slow 
response in the activation of debris removal cell. In the 
next phase, osteoblast cell activation occurs to begin the 
process of bone formation. At the macroscopic 
observation, the bone defect has been covered by a mass 
of tissue. This result is clarified by macroscopic 
examination. On the 14th day through the 42nd days 
postoperatively, the mass of the tissue is bone growth. 
At some locations, the trabecular bone grows near the 
edge of the bone near the periosteum showing 
osteoblastic activity. Most of the bones have formed 
compact structure (Fig. 2). 
 
Based on microscopic observations (3-4), the bone filled 
with decalcified BHA implant on the 14th day until the 
42nd day postoperatively has shown a proliferation of 
connective tissue into the implant. These results indicate 
that BHA is type 1 collagen, visible implant response 
that has formed trabeculae/bone sponge perfectly on day 
42, has osteoconductive property. According to Kalfas 
(2001), osteoconductive is the physical nature of graft in 
carrying out functions as an implant to support bone 
healing. Biomaterial that has osteoconductive property 
allows for the growth of osteogenic precursor cells into 
graft space.  
 
The growth of osteoblast into osteocyte in the bone 
indicates the degradation and tissue resorption of BHA-
GEN implant. The implant which expands to become 
porous will facilitate the cells around it to proliferate 
and penetrate, and differentiate within it. Osteoblast 
produces alkali phosphatase which functions to deposit 
calcium and phosphate into osteoid, osteoid will quickly 
form between BHA-GEN implant, because BHA 
implant component consists of calcium and phosphate. 
The bone marrow space contains many blood vessels 
and fat cells (Fig. 5), this shows the bone marrow is in a 
normal state. The implant is seen attached to the bone 
attached by connective tissue. In the BHA-GEN implant 
area with bone there is no inflammatory reaction 
because there is no inflammatory cell found in the area.  
 
On microscopic examination between the control group 
and the BHA intake group or the BHA-GEN implant on 
the 14th day to the 42nd day postoperatively is analyzed 
using Two way ANOVA statistical analysis, showing a 
significant difference between the control group, the 
BHA, and BHA-GEN osteoblast (p<0.0074) and 
osteoclast (p <0.0008) on the 14th day through the 42nd 
day, while in the osteocyte of the control group, BHA, 
and BHA- GEN there is no difference. In Table 1, the 
increased number of osteocyte shows the difference 
between days 14 and 42. On the other hand, osteoclast 
and osteoblast tend to increase in control, BHA, and 
BHA-GEN on the 14th day to the 42nd day. This shows 
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that the earliest occurrence of osteoclast activity is to 
degrade the inorganic component of the bone matrix, 
namely the alkaline salt of bone mineral HA. In BHA-
GEN implantation, osteoblast also increases from the 
14th day through the 42nd day, where the function of 
osteoblast synthesizes bone matrix protein and helps the 
calcification process.  
 
The result of radiological observation with X-ray 
equipment on bone from the 14th day to the 42nd day is 
able to show the development of bone growth. The 
radiology of positive control bone taken on the 14th day 
to the 42nd day postoperatively from the lateromedially 
direction shows the existence of a round shape on the 
defect in the bone, showing a zone radiolucent round 
shape which indicates damage to the bone due to 
drilling that is left without being given bone implant 
(Fig. 5). Damage in the physical structure of the bone 
which means the loss of calcium in that part will cause a 
decrease in bone opacity. Margin of bone damage is 
very clear.On (Figs. 6 and 7) BHA implantation taken 
on the 14th day to the 42nd day postoperatively with 
LM view. On day 14, the implant form still looks intact 
white. Normally, the change in implant margination 
indicates a reaction between the implant and 
surrounding bone tissue, while the appearance of the 
radiolucent zone around the implant accompanied by a 
decrease in implant opacity indicates to see implant 
absorption on days 28 and 42 indicates the state of the 
defect has begun to close with soft callus, bone defect 
filled with BG implants undergoes regeneration or 
closure quickly, seen from the soft callus formation so 
the bones quickly reconnect. Askarzadeh et al. (2005) 
state that change in the shape of the implant (becoming 
smaller and blurred) and increasing degree of blurring 
until implantation are probably lost related to bone 
growth and osteoblastic activity. A change that occurs 
in bone radiograph with BHA implant is not 
accompanied by a decrease in opacity and change in the 
shape of the implant, so this change cannot be a strong 
indicator to show the absorption of the implant.  
 
This is confirmed by the change that occurs in the 
radiographic image of BHA-GEN bone with LM view. 
The BHA-GEN implant seen on day 14 is also still in 
the form of a whole white sphere. A fairly good 
development is seen in the radiographic picture of 
BHA- GEN on day 28 (Fig. 7). Radiolucent strings are 
seen also on implant but still very fine. The change that 
occurs indicates the ongoing process of degradation and 
absorption of BHA-GEN implant and osteogenesis to 
form new bone tissue.  
 
 
 
 
Fig. 2. Transversal section of the distal femur of the control group for 14 (A), 28 (B) and 42 (C) days after surgery. The 
pictures showed a new bone structure formed in the edge of the bone defect area that was defined above ob = 
osteoblast, oc = osteoclast, os = osteocyte. The staining was using HE and the observation was using 100x 
magnification. 
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Figure 3.  Transversal section of the distal femur of rabbits given BHA implant on bone defect for 14 (A), 28 (B) and 42 
(C) days after surgery. The pictures showed the new bone structure that formed in the edge of bone defect 
consisting of ob = osteoblast, oc = osteoclast, os = osteocyte. The staining was using HE and the observation 
was using 100x magnification. 
 
 
 Fig. 4.  Transversal section of the distal femur of rabbits given BHA-GEN implant on bone defect for 14 (A), 28 (B) 
and 42 (C) days after surgery. The pictures showed the new bone structure that was formed in the edge of bone 
defect that consisting of ob = osteoblast, oc = osteoclast, os = osteocyte. The staining was using HE and the 
observation was using 100x magnification. 
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Fig. 5.  X-ray result from the right distal femur of rabbits on control days 14 (A), 28 (B) and 42 (C). Black circle 
indicated the location of the defect. 
 
 
 
 
Fig. 6. X-ray result from the right distal femur of rabbits that had been implanted with BHA on days 14 (A), 28 (B), and 
42 (C). White circle showed the location of the BHA implantation. 
 
 
This indicates the process of degradation of BHA-GEN 
implant continues. The shape of the implant looks 
fragmented and the size becomes a little smaller. This 
further confirms the absorption of the implant and the 
ongoing process of osteogenesis. Bone growth begins 
with the formation of osteoid by osteoblast of which 
90% of the main constituents is type 1 collagen as the 
result of implant degradation, namely GEL. Another 
degradation result from BHA-GEN implant supports the 
process of bone remodeling by forming osteocyte, this 
is a good process to accelerate the closure of bone 
defect. 
 
Bone damage for various reasons will activate all 
osteoblasts intraosseous and periosteum maximally in 
damaged areas. Shortly afterwards, a new number of 
osteoblasts are formed from osteoprogenitor cell, which 
are bone stem cells in the surface tissue that lines the 
bone. A callus formation from osteoblastic tissue and a 
new organic bone matrix which will be followed by 
withdrawal of calcium salt between the two edges of 
bone damage in a short time (Narbat et al 2006, Guyton 
& Hall 2007, Einhorn 2010). In the process of bone 
healing, there are two callus types, which are smooth 
callus (primary callus) and hard callus (secondary 
callus). Primary callus are formed in the third week to 
the fourth week after the occurrence of bone damage, 
whereas secondary callus are formed in the third to 
fourth month after the occurrence of bone damage. 
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Fig. 7. X-ray result from the right distal femur of rabbits that had been implanted with BHA-GEN on days 14 (A), 28 
(B), and 42 (C). White circle indicate the location of BHA-GEN implantation. 
 
Table 2. BALP levels in the control, BHA implant, and BHA-GEN implant groups on days 14, 28 and 42 after fracture 
induction. *) showed a significant difference between the control group with BHA or BHA-GEN group (p = 0.0361) 
on the 14th day. 
 
Group 
BALP level (X ± SD) level on the day of 
14th 28th 42nd 
Control  30.824 ± 2.381 25.734 ± 4.951 19.137 ± 2.181 
BHA 24.753 ± 1.502* 21.082 ± 1.504 19.725 ± 0.834 
BHA-GEN 20.242 ± 0.907* 22.026 ± 1.480 22.126 ± 2.474 
 
BALP is an isoenzyme that shows the formation of bone 
and the main enzyme that is present in inorganic change 
in pyrophosphate which is the inhibitor of bone 
mineralization (Goes et al 2012, Saosa et al 2015). 
BALP can be an early marker of osteoblast 
differentiation, and increases when progressive 
differentiation of osteoblasts occurs (Boanini et al 2008, 
Silva et al 2015). Analysis of BALP level seen in table 2 
shows that the analysis of the level of alkaline 
phosphatase enzyme on days 14, 28, and 42 shows an 
increase in soft callus formation on day 14 because 
there has been a reaction between osteoblast and 
collagen type 1 forming soft callus, osteoblast react 
switch calcium and phosphate to form hydroxyapatite 
which settles, this is accelerated by the presence of 
hydroxyapatite from the BHA and BHA-GEN implant 
matrices. The testing using Tukey's multiple 
comparisons test shows a significant difference between 
the BHA and BHA-GEN groups compared to control 
group (p <0.0361) on day 14 or phase production 
matrix, as well as on days 28 and 42. This result proves 
that bone alkaline phosphatase has enzymatic activity 
that shows an association with remodeling activity on 
the 14th day of repairing phase. Microscopic 
examination result with HE staining shows that the 
number of BHA and BHA-GEN osteocytes increase 
when compared with control group on days 14, 28, and 
42. 
 
Bone-specific alkaline phosphatase (BALP) is an 
isoenzyme for monitoring metabolic activity in bone 
synthesized in osteoblast and reflects osteoblast activity 
during bone formation, the production of the main 
protein in form is collagen type 1 (Greenblatt et al, 
2017). Alkaline phosphatase degrades matrix that is rich 
in proteoglycans and hydrolyzes high ester energy to 
provide phosphate ion resulting in the deposition of 
minerals with calcium in a collagen-rich matrix 
network. Precipitation of calcium and phosphate 
minerals with ALP can cause bone formation so that 
when bone formation can be increased then fracture 
healing can also be faster. 
 
Based on this research data, it shows that BHA and 
BHA-GEN implants can accelerate the process of bone 
growth. For this reason, the use of BHA and BHA-GEN 
implants is predicted to provide greater benefits along 
with ongoing efforts to develop a new strategy in the 
treatment of fracture illness. For this reason, it is 
necessary to further study the mechanism pathways and 
other markers in order to fully explain the process of 
bone remodeling acceleration.  
 
 
REFERENCES 
 
Askarzadeh K, People F, Moztarzadeh F (2005). 
Fabrication and characterization of a porous compo-
Fol Med Indones, Vol. 55 No. 3 September 2019 : 176-187           Khotib et al :  Bone Fracture Healing Using Natural Bovine Hydroxyapatite Implant 
 186 
site implant based on gelatin and hydroxyapatite for 
bone tissue engineering. Iranian Polymer Journal 14, 
511-520 
Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin 
SM, Baheiraei N, Kamali M, Nourani MR (2012). A 
porous hydroxyapatite/gelatin nanocomposite implant 
for bone tissue repair: In vitro and in vivo evaluation. 
Journal of Biomaterial Science 23, 2353-2368  
Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A 
(2008). Alendronate - hydroxyapatite nanocomposites 
and their interaction with osteoclasts and osteoblast - 
like cells. J. Biomaterials 29, 790-796 
Brunner & Suddarth (1997). Brunner and Suddarth’s 
Journal of Medical-Surgical Nursing . 7th Ed. 6-15. 
Budiatin Aniek Setiya, et al (2013). Gentamicin release 
from bovin-hydroxy-apatite-gelatin implant as a drug 
and bone filling delivery system. Indonesian Journal 
of Pharmacy and Pharmaceutical Sciences 1, 10-11 
 Budiatin AS, Zainuddin M, Khotib J (2014). 
Biocompatable composite as gentamicin delivery 
system for osteomyelitis and bone regeneration. 
International Journal of Pharmacy and Pharmaceutical 
Sciences 6, 223-226 
Capra P, Dorati R, Colonna C, Giovanna B, Pavanetto, 
F, Genta I, Conti B (2011). A preliminary study on the 
morphological and release properties of hydroxyapa-
tite-alendronate composite materials. Journal of 
Microencapsulation 28, 395-405 
Cattalini JP, Boccaccini AR, Habil Dr.-Ing, Lucangioli 
S, Mourino V (2012). Bisphosphonate-based strategies 
for bone tissue engineering and orthopedic implants. 
Tissue Engineering Part B 18, 5-8 
Chang J, Lin K (2015). Structure and properties of 
hydroxyapatite for biomedical applications. Hap for 
Biomedical Applications, 3-19 
Chao SC, Wang MJ, Pai NS, Yen SK (2015). 
Preparation and characterization of gelatin-
hydroxyapatite composite microspheres for hard tissue 
repair. Materials Science and Engineering C 57, 113-
122  
 Chen G, Deng C, Li YP (2012). TGF-β and BMP 
signaling in osteoblast differentiation and bone 
formation. International Journal of Biological 
Sciences 8, 272-288  
Cottrell JA, Vales FM, Schachter D, Wadsworth S, 
Gundlapalli R, Kapadia R, O'Connor JP (2010). 
Osteogenic activity of locally applied small molecule 
drugs in a rat femur defect model. Journal of 
Biomedicine and Biotechnology 597641, 1-2 
Einhorn TA (2010). Can an anti-fracture agent heal 
fractures?. Clinical Cases in Minerals and Bone 
Metabolism 6, 251-253 
Einhorn TA, Gerstenfeld LC (2014). Fracture healing: 
Mechanism and interventions. Nature Reviews 
Rheumatology, 355-337 
Ellis EG, Kathleen B (2007). The role of alkaline 
phosphatase in mineralization. Curr Opin Orthop 18, 
444-448 
Ferdiansyah, Rushadi D, Rantam FA, Aulani'am (2010). 
Regeneration of massive bone defect with bovine 
hydroxyapatite as mesenchymal stem cells' implants 
13, 179-195 
Fischer AH, Jacobson KA, Rose J, Zeller R (2008). 
Hematoxylin and eosin staining of tissue and cell 
sections. Cold Spring Harbor Protocols 3, 4986-4988 
Goes P, Melo MI, Dutra SC, Lima SPA, Lima V (2012). 
Effect of alendronate on bone - specific alkaline 
phosphatase on periodontal bone loss in rats. Archives 
of Oral Biology 57, 1537-1274 
Greenblatt MB, Tsi JN, Wein, MN (2017). Bone 
turnover markers in the diagnosis and monitoring of 
metabolic bone disease. Clinical Chemistry 63, 464-
474 
Guyton AC, Hall JE (2007). Medical physiology 
textbook. 9th Ed. Jakarta, EGC, p 6-7 
Hikmawati D, Maulida HN, Putra AP, Budiatin AS and 
Syahrom A (2019). Synthesis and characterization of 
nanohydroxyapatite-gelatin composite with streptomy-
cin as antituberculosis injectable bone substitute. 
International Journal of Biomaterials 2019 
Kalfas IH (2001). Principles of bone healing. Neurosurg 
Focus 10, 7-10 
Kim, HW, Knowles, JC, Kim HE (2004). 
Hydroxyapatite and gelatin composite foams 
processed via novel freeze-drying and crosslinking for 
use as temporary hard tissue implants. Journal of 
Biomedical Materials Research - Part A 72, 136-145 
Kusrini E, Sontang M (2012). Characterization of X-ray 
diffraction and electron spin resonance: Effects of 
sintering time and temperature on bovine 
hydroxyapatite. Rad Physical and Chem, 118-125 
Marsell R, Einhorn TA (2011). The biology of fracture 
healing. Injury 42, 551-555 
Maulida HN, Hikmawati D, Budiatin AS (2015). 
Injectable bone substitute paste based on 
hydroxyapatite, gelatin and streptomycin for spinal 
tuberculosis. The Spine Journal 4, 4-7 
Narbat KM, Orang F, Hashtjin SM, Goudarzi A (2006). 
Fabrication of porous hydroxyapatite-gelatin 
composite implans for bone tissue engineering. Iranian 
Biomed J. 10, 215-223 
Ning B, Zhao Y, Buza III JA, Li W, Wang W, Jia T 
(2017). Surgically-induced mouse models in the study 
of bone regeneration: Current models and future 
directions. Molecular Medicine Reports 15, 1017-
1023 
Pagani F, Francucci CM, Moro L (2005). Markers of 
bone turnover: Biochemical and clinical perspectives J 
Endocrinol Invest 28, 8-13 
Fol Med Indones, Vol. 55 No. 3 September 2019 : 176-187           Khotib et al :  Bone Fracture Healing Using Natural Bovine Hydroxyapatite Implant 
 187 
Raggatt LJ, Partridge NC (2010). Cellular and 
molecular mechanism of bone remodeling. Journal of 
Biological Chemistry 285, 25103-25108 
Ramirez-Fernandez MP, Calvo-Guirado JL, Delgado-
Ruiz RA, Mate-Sanchez del Val JE, Gomez-Moreno 
G, Guardia J (2011). Experimental model of bone 
response to xenografts of bovine origin (Endone®): a 
radiological and histomorphometric study. Clin.Oral 
Impl.Res 22, 727-734 
Schlickewei WC, Laaff G, Andresen A, Klatte OT, 
Rueger Mj, Ruesing J, Epple M, Lehmann W (2015). 
Bone augmentation using a new injectable bone graft 
substitute by combining calcium phosphate and 
bisphosphonate as composite - an animal model. 
Journal of Orthopedic Surgery and Research 10, 116 
Seibel MJ (2000). Molecular markers of bone turnover: 
biochemical, technical and analytical aspects. 
International Osteoporosis Foundation and National 
Osteoporosis Foundation 6, S18-29 
Sihombing D, Nursiswati, Prawesti A (2012). Overview 
of foot care and sensory sensation of feet in patients 
with type 2 diabetes mellitus in the dm polyclinic 
hospital 
Silva RF, Sasso GRD, Cerri ES, Simoes MJ, Cerri PS 
(2015). Review article. Biology of bone tissue: 
structure, function, and factors that influence bone 
cells. BioMed Research International 2015, 1-17 
Sousa CP, Dias IR, Pena ML, Camassa JA, Lourenco 
PJ, Judas FM, Gomes ME, Reis RL (2015). Bone 
turnover markers for early detection of fracture 
healing disturbances. Anais da Academia Brasileira de 
Ciencias 87, 1049-1061 
 
10/4/2019 Editorial Team
https://e-journal.unair.ac.id/FMI/about/editorialTeam 1/2
How to Submit
Guidelines for Authors
Online Submission
Document Template
Disclaimer
Focus and Scope
Publication Ethics
Article Proccessing Charge
Editorial Team
Peer Reviewers
Peer Review Process
Open Access Statement
Plagiarism Check
Archiving
Copyright
Contact
Old Website
OPEN JOURNAL SYSTEMS
Journal Help
USER
Username
Password
 Remember me
Login
NOTIFICATIONS
View
Subscribe
JOURNAL CONTENT
Search 
Search Scope 
All
Search
Browse
By Issue
By Author
HOME  ABOUT  LOGIN  REGISTER  SEARCH  CURRENT  ARCHIVES
Home > About the Journal > Editorial Team
EDITORIAL TEAM
EDITOR-IN CHIEF
Ni Made Mertaniasih, Department of Medical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
DEPUTY EDITORS
Muhammad Miftahussurur, Universitas Airlangga; Baylor College Medicine, Houston, US, Indonesia
EDITORIAL BOARD
Arend Frederik Bos, Division Neonatology, Faculty of Medical Sciences, University of Groningen, Netherlands
Hiroaki Kimura, Department of Physical Medicine and Rehabilitation, Hiroshima University Hospital, Japan
Jitti Hanprasertpong, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of
Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
Anucha Thatrimontrichai, Prince of Songkla University, Thailand
Surasak Sangkhathat, Pediatric Surgery Unit, Department of Surgery, Prince of Songkla University, Songkhla,
Thailand
Delvac Oceandy, University of Manchester, Manchester, United Kingdom
Brahmaputra Marjadi, Western Sydney University, Penrith, Australia
aryati aryati, Airlangga University, Indonesia
Viskasari Pintoko Kalanjati, Department of Anatomy and Histology, Faculty of Medicine, Airlangga University,
Surabaya, Indonesia
Irwanto Irwanto, Universitas Airlangga, Indonesia
Wihasto Suryaningtyas, Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
Asra Al Fauzi, Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Azimatul Karimah, Department of Psychiatry, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
Lucky Prasetiowati, Department of Anatomy & Histology, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
Bambang Purwanto, Department of Medical Physiology, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
MANAGING EDITOR
Ahmad Suryawan, Department of Pediatrics, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
PRODUCTION EDITORS
Moch. Zuhdy, Center for Medical Science Community, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
Athfiyatul Fatati, Center for Medical Science Community, Faculty of Medicine, Universitas Airlangga, Surabaya,
Indonesia
Alviana Nur Afifah, Center for Medical Science Community, Faculty of Medicine, Universitas Airlangga,
Surabaya, Indonesia
                 
  
Instruction for Author
Journal Policy
10/4/2019 Editorial Team
https://e-journal.unair.ac.id/FMI/about/editorialTeam 2/2
By Title
Other Journals
FONT SIZE  
  
View My Stats
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
License
